Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarterio-sclerotic effects in cardiac allografts
収録刊行物
-
- Circulation
-
Circulation 121 1413-1422, 2010